| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |